Sinha, S., Gould, L. J., Nigwekar, S. U., Serena, T. E., Brandenburg, V., Moe, S. M., . . . Chertow, G. M. (2022). The CALCIPHYX study: A randomized, double-blind, placebo-controlled, Phase 3 clinical trial of SNF472 for the treatment of calciphylaxis.
Citación estilo ChicagoSinha, Smeeta, et al. The CALCIPHYX Study: A Randomized, Double-blind, Placebo-controlled, Phase 3 Clinical Trial of SNF472 for the Treatment of Calciphylaxis. 2022.
Cita MLASinha, Smeeta, et al. The CALCIPHYX Study: A Randomized, Double-blind, Placebo-controlled, Phase 3 Clinical Trial of SNF472 for the Treatment of Calciphylaxis. 2022.
Precaución: Estas citas no son 100% exactas.